3′-hydroxy-3,4,5,4′-tetramethoxystilbene, the metabolite of resveratrol analogue DMU-212, inhibits ovarian cancer cell growth in vitro and in a mice xenograft model

Antiangiogenic agents in gynecological cancer: State of art and perspectives of clinical research

(2015) Angiolo Gadducci et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Activation of ERK1/2 is required for the antimitotic activity of the resveratrol analogue 3,4,5,4′-tetramethoxystilbene (DMU-212) in human melanoma cells

(2015) Vasilis Pericles Androutsopoulos et al.   EXPERIMENTAL DERMATOLOGY

Induction of G2/M Arrest by Berberine via Activation of PI3K/Akt and p38 in Human Chondrosarcoma Cell Line

(2015) Seong-Hui Eo et al.   ONCOLOGY RESEARCH

Mutant p53 promotes ovarian cancer cell adhesion to mesothelial cells via integrin β4 and Akt signals

(2015) Jong-Gyu Lee et al.   Scientific Reports

The Impact of Hedgehog Signaling Pathway on DNA Repair Mechanisms in Human Cancer

(2015) Erhong Meng et al.   Cancers

From French Paradox to Cancer Treatment: Anti-cancer Activities and Mechanisms of Resveratrol

(2014) Xuan Yang et al.   Anti-Cancer Agents in Medicinal Chemistry

DMU-212 inhibits tumor growth in xenograft model of human ovarian cancer

(2014) Hanna Piotrowska et al.   BIOMEDICINE & PHARMACOTHERAPY

Old, new and emerging functions of caspases

(2014) S Shalini et al.   CELL DEATH AND DIFFERENTIATION

Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas

(2014) Jianyuan Wu et al.   MEDICAL ONCOLOGY

Enhancing the Delivery of Resveratrol in Humans: If Low Bioavailability is the Problem, What is the Solution?

(2014) James Smoliga et al.   MOLECULES

Different susceptibility of colon cancer DLD-1 and LOVO cell lines to apoptosis induced by DMU-212, a synthetic resveratrol analogue

(2013) Hanna Piotrowska et al.   TOXICOLOGY IN VITRO

The central role of initiator caspase-9 in apoptosis signal transduction and the regulation of its activation and activity on the apoptosome

(2012) Maximilian L. Würstle et al.   EXPERIMENTAL CELL RESEARCH

Resveratrol analogue 3,4,4′,5-tetramethoxystilbene inhibits growth, arrests cell cycle and induces apoptosis in ovarian SKOV‐3 and A-2780 cancer cells

(2012) Hanna Piotrowska et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Targeting p53 to mitochondria for cancer therapy

(2011) Lorenzo Galluzzi et al.   CELL CYCLE

FAS-Associated Factor 1 (FAF1): Diverse functions and implications for oncogenesis

(2011) Craig W. Menges et al.   CELL CYCLE

Anticancer effects of the metabolic products of the resveratrol analogue, DMU-212: Structural requirements for potency

(2011) Vasilis P. Androutsopoulos et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Preparation and characterization of realgar nanoparticles and their inhibitory effect on rat glioma cells

(2011) Yan-li An et al.   International Journal of Nanomedicine

Biological activity of piceatannol: Leaving the shadow of resveratrol

(2011) Hanna Piotrowska et al.   MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH

TNFAIP8: A new effector for Galpha(i) coupling to reduce cell death and induce cell transformation

(2010) Benoit Laliberté et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Resveratrol analog trans 3,4,5,4′-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol

(2008) Zengshuan Ma et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY